Occurrence and detection of extended-spectrum beta-lactamases in members of the family Enterobacteriaceae at a veterans medical center: Seek and you may find

被引:120
作者
Coudron, PE [1 ]
Moland, ES [1 ]
Sanders, CC [1 ]
机构
[1] CREIGHTON UNIV,SCH MED,DEPT MED MICROBIOL,OMAHA,NE 68178
关键词
D O I
10.1128/JCM.35.10.2593-2597.1997
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
A total of 907 consecutive isolates of members of the family Enterobacteriaceae recovered during a 20-week period were tested for production of extended-spectrum beta-lactamases (ESBLs) by the double-disk (DD) potentiation method. Of 84 DD-positive isolates, 83 (9.2%) produced ESBLs based on isoelectric focusing, SHV-derived ESBLs and several TEM-derived ESBLs were present in nine species, including the first isolate of Citrobacter koserii and Morganella morganii known to harbor an SHV-derived ESBL. Results of testing 58 nonrepeat isolates for ESBL production by several recommended methods were as follows (percent detected in parentheses): DD method with aztreonam (95), ceftazidime (79), ceftriaxone (88), or cefpodoxime (90); broth microdilution method with ceftazidime (86) or cefotaxime (91) alone or in combination with clavulanate; and the standard disk diffusion method with new breakpoints and standard concentrations of aztreonam (78), ceftazidime (79), ceftriaxone (83), or cefpodoxime (98) or a novel concentration (5 mu g) of ceftazidime (88), In three instances during an extended part of the study, an ESBL-producing isolate and a non-ESBL-producing isolate of the same species were recovered from a single blood culture bottle. These data indicate that ESBLs occur in several species of Enterobacteriaceae and at a relatively high incidence at our institution and that the standard disk diffusion method with cefpodoxime and the DD method,vith several beta-lactams are practical and cost-effective methods for detecting ESBL-producing isolates of Enterobacteriaceae.
引用
收藏
页码:2593 / 2597
页数:5
相关论文
共 33 条
[1]   A NEW PLASMIDIC CEFOTAXIMASE IN A CLINICAL ISOLATE OF ESCHERICHIA-COLI [J].
BAUERNFEIND, A ;
GRIMM, H ;
SCHWEIGHART, S .
INFECTION, 1990, 18 (05) :294-298
[2]   MULTIPLY RESISTANT KLEBSIELLA-PNEUMONIAE STRAINS FROM 2 CHICAGO HOSPITALS - IDENTIFICATION OF THE EXTENDED-SPECTRUM TEM-12 AND TEM-10 CEFTAZIDIME-HYDROLYZING BETA-LACTAMASES IN A SINGLE ISOLATE [J].
BRADFORD, PA ;
CHERUBIN, CE ;
IDEMYOR, V ;
RASMUSSEN, BA ;
BUSH, K .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (04) :761-766
[3]   A FUNCTIONAL CLASSIFICATION SCHEME FOR BETA-LACTAMASES AND ITS CORRELATION WITH MOLECULAR-STRUCTURE [J].
BUSH, K ;
JACOBY, GA ;
MEDEIROS, AA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (06) :1211-1233
[4]   INCIDENCE OF STRAINS PRODUCING EXTENDED SPECTRUM BETA-LACTAMASES IN ARGENTINA [J].
CASELLAS, JM ;
GOLDBERG, M .
INFECTION, 1989, 17 (06) :434-436
[5]   Survey of prevalence of extended spectrum beta-lactamases among Enterobacteriaceae [J].
Chanal, C ;
Sirot, D ;
Romaszko, JP ;
Bret, L ;
Sirot, J .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1996, 38 (01) :127-132
[6]   CONCOMITANT DISSEMINATION OF 3 EXTENDED-SPECTRUM BETA-LACTAMASES AMONG DIFFERENT ENTEROBACTERIACEAE ISOLATED IN A FRENCH HOSPITAL [J].
DECHAMPS, C ;
SIROT, D ;
CHANAL, C ;
POUPART, MC ;
DUMAS, MP ;
SIROT, J .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1991, 27 (04) :441-457
[7]   CHARACTERIZATION OF CEFTRIAXONE-RESISTANT ENTEROBACTERIACEAE - A MULTICENTER STUDY IN 26 FRENCH HOSPITALS [J].
GOLDSTEIN, FW ;
PEAN, Y ;
ROSATO, A ;
GERTNER, J ;
GUTMANN, L .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1993, 32 (04) :595-603
[8]   Detection of extended-spectrum beta-lactamases in clinical isolates of Klebsiella pneumoniae and Escherichia coli [J].
Jacoby, GA ;
Han, P .
JOURNAL OF CLINICAL MICROBIOLOGY, 1996, 34 (04) :908-911
[9]  
JARLIER V, 1988, REV INFECT DIS, V10, P867
[10]   IN-VITRO ACTIVITIES OF VARIOUS BETA-LACTAM ANTIMICROBIAL AGENTS AGAINST CLINICAL ISOLATES OF ESCHERICHIA-COLI AND KLEBSIELLA SPP RESISTANT TO OXYIMINO CEPHALOSPORINS [J].
JETT, BD ;
RITCHIE, DJ ;
REICHLEY, R ;
BAILEY, TC ;
SAHM, DF .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (05) :1187-1190